Concepedia

Author

Dan Kiel

Pfizer (United States)

Also Known As

D Kiel, Dan Kiel

11

Publications

514

Citations

6

H-Index

19

Concepts

All Affiliations

Pfizer (United States)Novo Nordisk (Denmark)University of Copenhagen
DK

About

Dan Kiel is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

421

2

Biochemistry

4

4

381

3

Natural Sciences

3

3

328

4

Cell Biology

1

1

63

5

Cellular Physiology

1

1

63

Dan Kiel

×

6

Publications

508

Citations

6

H-Index

YearCitations

Small-molecule agonists for the glucagon-like peptide 1 receptor

Lotte Bjerre Knudsen, Dan Kiel, Min Teng,

Proceedings of the National Academy of Sciences

2007

223

Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1<i>H</i>-indol-4-ylmethylene]hydrazide

Peter Madsen, Anthony Ling, Michael Plewe,

Journal of Medicinal Chemistry

2002

87

Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor

Min Teng, Michael D. Johnson, Christine K. Thomas,

Bioorganic & Medicinal Chemistry Letters

2007

63

New β-Alanine Derivatives Are Orally Available Glucagon Receptor Antagonists

Jesper Lau, Carsten Behrens, Ulla G. Sidelmann,

Journal of Medicinal Chemistry

2007

53

Identification of Alkylidene Hydrazides as Glucagon Receptor Antagonists

Anthony Ling, Yufeng Hong, Javier González,

Journal of Medicinal Chemistry

2001

42

Human glucagon receptor antagonists based on alkylidene hydrazides

Anthony Ling, Michael Plewe, Javier González,

Bioorganic & Medicinal Chemistry Letters

2002

40

Page 1